[go: up one dir, main page]

CU20140094A7 - Sistema para la administración de fármacos - Google Patents

Sistema para la administración de fármacos

Info

Publication number
CU20140094A7
CU20140094A7 CU2014000094A CU20140094A CU20140094A7 CU 20140094 A7 CU20140094 A7 CU 20140094A7 CU 2014000094 A CU2014000094 A CU 2014000094A CU 20140094 A CU20140094 A CU 20140094A CU 20140094 A7 CU20140094 A7 CU 20140094A7
Authority
CU
Cuba
Prior art keywords
core
membrane
drug administration
administration system
intermediate layer
Prior art date
Application number
CU2014000094A
Other languages
English (en)
Other versions
CU24431B1 (es
Inventor
Heikki Lyytikäinen
Harri Jukarainen
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47666152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU20140094(A7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of CU20140094A7 publication Critical patent/CU20140094A7/es
Publication of CU24431B1 publication Critical patent/CU24431B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Un sistema para la administración de fármacos para la liberación controlada de sustancias terapéuticamente activas a una tasa de liberación predeterminada, esencialmente constante durante un período de tiempo prolongado. El sistema de administración comprende al menos un núcleo que comprende dicha (s) sustancia (s) terapéuticamente activa (s), al menos una membrana que encierra el núcleo y una capa intermedia de un material sustancialmente inerte, en donde la capa intermedia se aplica entre el núcleo y la membrana o entre las dos capas de membrana.
CU2014000094A 2012-01-23 2013-01-22 Sistema para la administración de fármacos CU24431B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20125069 2012-01-23
PCT/FI2013/050068 WO2013110856A1 (en) 2012-01-23 2013-01-22 A drug delivery system

Publications (2)

Publication Number Publication Date
CU20140094A7 true CU20140094A7 (es) 2014-11-27
CU24431B1 CU24431B1 (es) 2019-07-04

Family

ID=47666152

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2014000094A CU24431B1 (es) 2012-01-23 2013-01-22 Sistema para la administración de fármacos

Country Status (38)

Country Link
US (1) US10500381B2 (es)
EP (1) EP2806893B1 (es)
JP (1) JP6236401B2 (es)
KR (1) KR102004014B1 (es)
CN (1) CN104144702B (es)
AR (1) AR089765A1 (es)
AU (1) AU2013213514B2 (es)
BR (1) BR112014017834B1 (es)
CA (1) CA2861947A1 (es)
CL (1) CL2014001935A1 (es)
CO (1) CO7020911A2 (es)
CR (1) CR20140358A (es)
CU (1) CU24431B1 (es)
CY (1) CY1120773T1 (es)
DK (1) DK2806893T3 (es)
DO (1) DOP2014000171A (es)
EA (1) EA032208B1 (es)
EC (1) ECSP14010605A (es)
ES (1) ES2691635T3 (es)
HR (1) HRP20181707T1 (es)
IL (1) IL233599B (es)
LT (1) LT2806893T (es)
MX (1) MX355961B (es)
MY (1) MY172812A (es)
NZ (1) NZ627461A (es)
PE (1) PE20141818A1 (es)
PH (1) PH12014501654B1 (es)
PL (1) PL2806893T3 (es)
PT (1) PT2806893T (es)
RS (1) RS57911B1 (es)
SG (1) SG11201404032SA (es)
SI (1) SI2806893T1 (es)
TR (1) TR201815247T4 (es)
TW (1) TWI626951B (es)
UA (1) UA116197C2 (es)
UY (1) UY34583A (es)
WO (1) WO2013110856A1 (es)
ZA (1) ZA201406206B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2919903T3 (pl) 2012-11-14 2020-12-14 W.R. Grace & Co. - Conn. Kompozycje zawierające materiał biologicznie aktywny i nieuporządkowany tlenek nieorganiczny
CN105392454B (zh) * 2014-06-28 2018-05-08 安德罗玛克实验室股份有限公司 用于预防早产的含有延长、不变和持续释放的孕酮的环扎子宫托
CA3008940A1 (en) * 2015-12-21 2017-06-29 Bayer Oy A method of manufacturing a vaginal ring
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
PE20211195A1 (es) * 2017-09-27 2021-07-01 Bayer Oy Un metodo para modificar la liberacion de un agente terapeuticamente activo de una matriz elastomerica
CN109954198B (zh) * 2017-12-25 2021-10-12 先健科技(深圳)有限公司 药物球囊及其制备方法
BR112021016369A2 (pt) * 2019-02-19 2021-10-19 Particle Sciences Inc. Dispositivo de distribuição, e, métodos para produzir o dispositivo de distribuição de fármaco e para distribuir um ou mais agentes farmacêuticos ativos

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303306B1 (en) * 1987-08-08 1993-03-10 Akzo N.V. Contraceptive implant
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor
NZ330726A (en) * 1998-06-18 2000-10-27 Dec Res Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
WO2001085132A1 (en) 2000-05-10 2001-11-15 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
WO2002032433A1 (en) * 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
JP2005503389A (ja) * 2001-08-31 2005-02-03 シエーリング オサケユイチア 薬物送達システム
DE10209979A1 (de) 2002-03-07 2003-09-25 Ratiopharm Gmbh Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung
US20050013863A1 (en) * 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
PT1740154E (pt) 2004-03-12 2009-09-11 Biodel Inc Composições de insulina com absorção melhorada
ES2293193T5 (es) 2004-07-13 2012-06-13 Bayer Schering Pharma Oy Sistema de suministro retardado con descarga inicial controlada
US20060024362A1 (en) * 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
EP1833469A2 (en) * 2005-01-03 2007-09-19 Lupin Ltd. Pharmaceutical composition of acid labile substances
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20060165776A1 (en) * 2005-08-31 2006-07-27 Ramesh Sesha Antidepressant oral pharmaceutical compositions
US8137327B2 (en) 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
EP2097063B1 (en) * 2006-11-20 2013-08-07 Intervet International B.V. Helically-shaped drug delivery system
AR066166A1 (es) * 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
TW200927141A (en) 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI121000B (fi) 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
US20130287856A1 (en) * 2010-12-27 2013-10-31 Virginie Caprasse Drug Delivery Dispersion And Film Formed Therefrom

Also Published As

Publication number Publication date
UA116197C2 (uk) 2018-02-26
MX355961B (es) 2018-05-07
IL233599A0 (en) 2014-08-31
KR20140127262A (ko) 2014-11-03
BR112014017834B1 (pt) 2021-05-18
CA2861947A1 (en) 2013-08-01
TW201343204A (zh) 2013-11-01
ES2691635T3 (es) 2018-11-28
UY34583A (es) 2013-09-02
MX2014008906A (es) 2014-08-26
PH12014501654A1 (en) 2014-10-13
KR102004014B1 (ko) 2019-07-25
HK1203802A1 (en) 2015-11-06
CN104144702A (zh) 2014-11-12
EA201400834A1 (ru) 2014-12-30
PT2806893T (pt) 2018-11-09
WO2013110856A1 (en) 2013-08-01
BR112014017834A8 (pt) 2017-07-11
JP2015504083A (ja) 2015-02-05
NZ627461A (en) 2016-07-29
LT2806893T (lt) 2018-12-10
CU24431B1 (es) 2019-07-04
EA032208B1 (ru) 2019-04-30
AU2013213514A1 (en) 2014-08-07
BR112014017834A2 (es) 2017-06-20
SI2806893T1 (sl) 2019-02-28
CR20140358A (es) 2014-11-17
IL233599B (en) 2019-07-31
ZA201406206B (en) 2019-06-26
ECSP14010605A (es) 2015-12-31
SG11201404032SA (en) 2014-08-28
HRP20181707T1 (hr) 2019-02-22
PH12014501654B1 (en) 2014-10-13
DOP2014000171A (es) 2014-08-15
US20140350488A1 (en) 2014-11-27
CN104144702B (zh) 2018-03-06
PE20141818A1 (es) 2014-12-18
US10500381B2 (en) 2019-12-10
TR201815247T4 (tr) 2018-11-21
MY172812A (en) 2019-12-12
PL2806893T3 (pl) 2019-01-31
CO7020911A2 (es) 2014-08-11
TWI626951B (zh) 2018-06-21
CL2014001935A1 (es) 2015-04-10
JP6236401B2 (ja) 2017-11-22
AR089765A1 (es) 2014-09-17
EP2806893B1 (en) 2018-07-18
CY1120773T1 (el) 2019-12-11
DK2806893T3 (en) 2018-11-05
AU2013213514B2 (en) 2017-07-13
EP2806893A1 (en) 2014-12-03
RS57911B1 (sr) 2019-01-31

Similar Documents

Publication Publication Date Title
DOP2014000171A (es) Sistema para la administración de fármacos
EP2589379A4 (en) TRANSDERMAL DRUG DELIVERY SYSTEM CONTAINING DEPPEZIL
MX354444B (es) Dispositivos implantables heterogeneos para suministro de medicamento.
CO2019000643A2 (es) Formulaciones gastrorretentivas orales y usos de las mismas
CY1116638T1 (el) Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας
WO2014116650A3 (en) Transdermal drug delivery system and method
MX376862B (es) Composicion que comprende un agonista de receptor de serotonina y una dicetopiperazina para el tratamiento de migrañas.
LTPA2019508I1 (lt) Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui
MX2020011961A (es) Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas.
SG194155A1 (en) Multilayer thin film drug delivery device and methods of making and using the same
CL2009001556A1 (es) Sistema de administración transdermica de fármacos que comprende una capa que contiene fármaco que comprende una matriz polimérica que contiene estradiol como unico fármaco; método de elaboración; útil para administrar estradiol.
SV2015005115A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
DK2613784T3 (da) Indretning til transdermal indgivelse af lægemiddel
EA201001244A1 (ru) Система доставки лекарственного средства со стабилизирующим эффектом
MX2016008138A (es) Sistema para el suministro transdermico de ingredientes activos.
ES2570205T3 (es) Sistema terapéutico transdérmico con pequeña tendencia a la cristalización espontánea
CL2013000477A1 (es) Formulacion farmaceutica oral de liberacion inmediata que comprende nalbufina o una sal de la misma, y al menos, un soporte de granulacion hidrofilo, un aglutinante hidrofilo y un lubricante, util para el tratamiento del dolor y la dependencia a los opioides.
BR112013029199A2 (pt) sistema de distribuição de fármacos, dispositivo de distribuição de dois fármacos, método para preparar o mesmo, comprimido para administração sublingual de um ingrediente ativo, e, método para a administração de um ingrediente ativo a um indivíduo
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
MY166972A (en) Transdermal delivery system containing galantamine or salts thereof
EP2939663A4 (en) MELT EXTRUDED PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE AND MEDICAMENT FOR ORAL ADMINISTRATION THEREWITH
TH95747A (th) การนำส่งทางผิวหนังของเมปตาซินอล
TH164080A (th) รูปเเบบยาของเเข็ง
TH153173A (th) ระบบการนำส่งยา
UY30536A1 (es) Sistema de liberacion farmacéutica controlada, particularmente administracion oral de sustancias activas con solubilidades de ph, preparacion y aplicacion.